查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1766100

長讀定序市場：2032 年未來預測－依產品、技術、應用、最終使用者和地區進行分析

Long Read Sequencing Market Forecasts to 2032 - Global Analysis By Product, Technology (Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Synthetic Long-Read Sequencing and Other Technologies), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球長讀定序市場預計在 2025 年將達到 13.2 億美元，到 2032 年將達到 58.7 億美元，預測期內的複合年成長率為 23.7%。

一種被稱為「長讀定序」的技術可以創建長而連續的DNA鏈讀取，通常長度為數千到數百萬個鹼基對。與傳統的短讀技術相比，它可以更精確地定位包含結構變異、重複序列和全長轉錄物的複雜基因組區域。牛津奈米孔平台和太平洋生物科學公司的SMRT等技術使即時定序和極簡樣品製備成為可能。長讀定序是基因組學研究中的強大工具，因為它透過提供遺傳資訊的背景和連續性來改善基因組組裝、臨床診斷和演化研究。

精確基因組組裝的需求不斷增加

複雜的基因組區域難以透過短讀長定序方法解析，但長讀長定序方法使其成為可能。它可以更精確地檢測大片段插入和缺失、重複序列以及結構變異。個人化醫療、疾病研究和演化研究等領域的應用都依賴這種準確性。隨著學術界和醫療相關人員越來越重視準確且全面的基因數據，長讀長平台正變得越來越受歡迎。為了滿足日益成長的需求，業內公司正在投資先進的定序系統。

高成本、錯誤率高

由於技術要求高，需要昂貴的設備和化學品，限制了它們在小型實驗室中的應用。由於每個樣本的定序成本高昂，它們在更廣泛的臨床和科研環境中的應用也受到限制。此外，長讀長定序輸出的錯誤率會影響資料的準確性和可靠性。這通常需要對短讀長進行額外的定序以進行檢驗，這既昂貴又耗時。因此，用戶不願完全遷移到長讀長平台，限制了市場擴張。

擴大在臨床診斷和個人化醫療的應用

長讀長定序可以精確檢測基因融合、複雜的基因組區域以及短讀長定序經常忽略的結構變化。這種精準度對於診斷複雜疾病和罕見基因異常至關重要。它能夠根據每位患者獨特的基因組成客製化治療方案，從而實現個人化醫療。此外，該技術還有助於癌症基因組分析和非侵入性產前檢測。隨著精準醫療和客製化醫療需求的日益成長，長讀長定序正日益普及。

來自短讀技術和新興定序平台的競爭

短讀長方法易於採用，具有成熟且廣泛可用的基礎設施和方便用戶使用的方法。由於其高準確度和高通量，短讀長方法在許多臨床和研究應用中仍然被廣泛使用。新的平台正在彌補讀長的差距，同時又不犧牲價格。長讀長供應商面臨創新和快速降價的壓力。因此，市場擴張面臨緩慢的採用和日益激烈的價格競爭。

COVID-19的影響

COVID-19 疫情加速了基因組學研究和診斷方法的開發，對長讀長定序市場產生了積極影響。精準快速病原體檢測的需求日益成長，刺激了對定序技術的投資。長讀長定序在研究病毒突變、改進監測和輔助疫苗研發方面發揮了關鍵作用。此外，政府與生技公司之間的合作也擴大了全球定序能力。儘管最初供應鏈中斷，但由於人們對基因組學工具在醫療準備和回應方面的認知不斷提高，市場實現了顯著成長。

預計在預測期內，消耗品部分將成長至最大的部分。

由於每次定序運作都有固定的需求，預計耗材領域將在預測期內佔據最大的市場佔有率。耗材包括試劑、套件和流動槽，這些對於準確且有效率地產生長讀長數據至關重要。耗材技術的進步提高了讀取長度、準確性和吞吐量，吸引了更多的研究和臨床應用。基因組學和腫瘤學等領域對長讀長定序的日益普及，推動了對高性能耗材的需求。這種穩定成長的需求將增強整體市場的成長和盈利。

預計在預測期內，醫院和醫療保健提供者部門將以最高的複合年成長率成長。

由於患者診斷和個人化治療對準確且全面的基因組數據的需求不斷成長，預計醫院和醫療保健提供者領域將在預測期內實現最高成長。這些機構擴大採用長讀長定序來識別短讀長方法可能遺漏的複雜基因突變。罕見遺傳疾病和癌症的增加進一步推動了臨床環境中對準確基因組分析的需求。將長讀長定序技術整合到醫院實驗室可以改善診斷工作流程並提升病患預後。此外，政府資助和官民合作關係正在推動先進測序技術在醫療保健基礎設施中的應用。

比最大的地區

在預測期內，亞太地區預計將佔據最大的市場佔有率，這得益於基因組研究投入的增加、政府對精準醫療的支持以及遺傳疾病盛行率的上升。中國、日本和印度等國家正在擴大其生物技術基礎設施和研究能力。當地大學與全球生物技術公司之間的合作正在促進技術的採用。此外，個人化醫療需求的不斷成長以及人們對基因組檢測的認知不斷提高，也全部區域的市場擴張做出了重大貢獻。

複合年成長率最高的地區：

預計北美地區在預測期內的複合年成長率最高，這得益於該地區擁有領先的企業、先進的醫療基礎設施以及高額的研發支出。尤其是美國，它在尖端基因組技術在臨床和研究應用方面的應用方面處於領先地位。該地區受益於完善的資金籌措架構、健全的監管制度以及廣泛的產學合作。與亞太地區不同，北美市場成熟，能夠快速部署創新的群體定序平台和大規模的群體基因組學計畫。

免費客製化服務

本報告的所有訂閱者均可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他公司（最多 3 家）進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第 2 章 簡介

  • 概述
  • 相關利益者
  • 分析範圍
  • 分析方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 分析方法
  • 分析材料
    • 主要研究資料
    • 二手研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 介紹
  • 驅動程式
  • 限制因素
  • 市場機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代產品的威脅
  • 新參與企業的威脅
  • 企業之間的競爭

5. 全球長讀定序市場（依產品）

  • 裝置
    • SMRT定序儀
    • 奈米孔定序儀
  • 耗材
    • 試劑
    • 流動池
  • 服務
    • 定序服務
    • 數據分析服務

6. 全球長讀定序市場（依技術）

  • 單分子即時（SMRT）定序
  • 奈米孔定序
  • 合成長讀定序
  • 其他技術

7. 全球長讀定序市場（按應用）

  • 基因組學
    • 全基因組定序（WGS）
    • 從頭定序
    • 結構突變檢測
  • 轉錄組學
    • 全長mRNA定序
    • 異構體鑑定
  • 表觀遺傳學
    • DNA甲基化分析
    • 組蛋白修飾檢測
  • 總體基因體學
  • 其他用途

8. 全球長讀定序市場（依最終用戶）

  • 製藥和生物技術公司
  • 臨床實驗室
  • 醫院和醫療機構
  • CRO（委外研發機構）
  • 其他最終用戶

9. 全球長讀定序市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：主要趨勢

  • 合約、商業夥伴關係和合資企業
  • 企業合併與收購（M&A）
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • Illumina Inc.
  • BGI Genomics
  • MGI Tech
  • 10x Genomics
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Qiagen
  • Bionano Genomics
  • Element Biosciences
  • Quantapore Inc.
  • Universal Sequencing Technology
  • BaseClear BV
  • Cantata Bio, LLC
  • Future Genomics Technologies BV
  • MicrobesNG
  • SeqLL, Inc.
Product Code: SMRC29956

According to Stratistics MRC, the Global Long Read Sequencing Market is accounted for $1.32 billion in 2025 and is expected to reach $5.87 billion by 2032 growing at a CAGR of 23.7% during the forecast period. The technique known as "long read sequencing" creates lengthy, continuous reads of DNA strands, usually ranging in length from thousands to millions of base pairs. It enables more precise mapping of intricate genomic areas, including structural variations, repetitive sequences, and full-length transcripts, in contrast to conventional short-read techniques. Real-time sequencing and minimal sample preparation are made possible by technologies such as Oxford Nanopore's platforms and Pacific Biosciences' SMRT. Long read sequencing is a potent tool in genomics research because it improves genome assembly, clinical diagnostics, and evolutionary studies by giving genetic information more context and continuity.

Market Dynamics:

Driver:

Increasing demand for accurate genome assembly

Complex genomic areas are challenging to resolve with short reads, but long read sequencing methods make this possible. They provide more precision in detecting big insertions or deletions, repetitive sequences, and structural alterations. Applications in personalised treatment, disease research, and evolutionary studies all depend on this accuracy. Long read platforms are becoming more and more popular as academics and medical professionals place a higher value on accurate and comprehensive genetic data. In order to satisfy this rising demand, industry participants are investing in sophisticated sequencing systems.

Restraint:

High cost and error rates

The sophisticated technology required necessitates costly equipment and chemicals, which limits small labs' access to it. Its use in extensive clinical and scientific settings is restricted by the high expense of sequencing each sample. Furthermore, the correctness and dependability of data are jeopardised by the error rates in long-read outputs. This frequently calls for additional short-read sequencing for validation, which raises the expense and time. As a result, users hesitate to fully transition to long-read platforms, slowing market expansion.

Opportunity:

Growing use in clinical diagnostics and personalized medicine

Gene fusions, complicated genomic areas, and structural changes that short reads frequently overlook can be accurately detected by long read sequencing. For the diagnosis of complex diseases and rare genetic abnormalities, this accuracy is essential. This helps personalised medicine by customising care according to each patient's distinct genetic composition. Additionally, the technology helps cancer genomics and non-invasive prenatal diagnostics. Long read sequencing is gaining traction as the need for accurate, customised healthcare increases.

Threat:

Competition from short read technologies and emerging sequencing platforms

Adoption is facilitated by the established, widely used infrastructure and user familiarity of short read methods. Because of its precision and high throughput, short reads are still used in many clinical and research applications. New platforms are bridging the read-length divide without sacrificing price. Long read suppliers are under pressure to innovate and cut prices quickly as a result. Market expansion is therefore confronted with slower adoption and more intense pricing competition.

Covid-19 Impact

The COVID-19 pandemic positively impacted the Long Read Sequencing market by accelerating genomic research and diagnostic development. Increased demand for accurate and rapid pathogen detection drove investments in sequencing technologies. Long read sequencing played a vital role in studying virus mutations, improving surveillance, and supporting vaccine development. Additionally, collaborative efforts between governments and biotech firms expanded sequencing capacity globally. Despite initial supply chain disruptions, the market experienced significant growth due to heightened awareness of genomic tools in healthcare preparedness and response.

The consumables segment is expected to be the largest during the forecast period

The consumables segment is expected to account for the largest market share during the forecast period, due to ensured recurring demand through each sequencing run. These include reagents, kits, and flow cells, which are essential for accurate and efficient long-read data generation. Technological advancements in consumables enhance read length, accuracy, and throughput, attracting more research and clinical applications. As the adoption of long-read sequencing grows in fields like genomics and oncology, the need for high-performance consumables rises. This steady and expanding demand strengthens the overall market growth and profitability.

The hospitals & healthcare providers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals & healthcare providers segment is predicted to witness the highest growth rate, due to the growing demand for accurate and comprehensive genomic data for patient diagnostics and personalized treatment. These institutions increasingly adopt long read sequencing to identify complex genetic variations that short read methods may miss. Rising incidences of rare genetic disorders and cancer further drive the need for precise genomic analysis in clinical settings. Integration of long read sequencing into hospital labs improves diagnostic workflows and enhances patient outcomes. Additionally, government funding and public-private partnerships support the adoption of advanced sequencing technologies in healthcare infrastructure.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to increasing investments in genomics research, government support for precision medicine, and the rising prevalence of genetic disorders. Countries like China, Japan, and India are expanding their biotechnology infrastructure and research capabilities. Collaborations between local universities and global biotech firms are fuelling technological adoption. Moreover, the growing demand for personalized healthcare and increasing awareness about genomic testing contribute significantly to market expansion across the region.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to the presence of major players, advanced healthcare infrastructure, and high R&D expenditure. The U.S., in particular, leads in the adoption of cutting-edge genomic technologies for clinical and research applications. The region benefits from established funding frameworks, robust regulatory systems, and widespread academic-industry collaborations. Unlike Asia Pacific, North America's market maturity allows for rapid deployment of innovative sequencing platforms and large-scale population genomics initiatives.

Key players in the market

Some of the key players profiled in the Long Read Sequencing Market include Pacific Biosciences, Oxford Nanopore Technologies, Illumina Inc., BGI Genomics, MGI Tech, 10x Genomics, Agilent Technologies, Thermo Fisher Scientific, Qiagen, Bionano Genomics, Element Biosciences, Quantapore Inc., Universal Sequencing Technology, BaseClear BV, Cantata Bio, LLC, Future Genomics Technologies B.V., MicrobesNG and SeqLL, Inc.

Key Developments:

In May 2025, PacBio expanded its distribution agreement with Xi'an-based Haorui Gene, making Haorui the distributor for the Vega benchtop system across China and providing product support. Haorui had already deployed 10 Sequel II and Revio sequencers, focusing on blood typing genomics and HLA testing.

In October 2024, PacBio signed a research collaboration agreement to accelerate cancer genomics research in Asia, leveraging both its long-read (Revio) and short-read (Onso) sequencing platforms. The collaboration, supported by DKSH, aims to expand multi-omics research and precision oncology in the region.

In July 2024, Oxford Nanopore and Plasmidsaurus entered an expanded, multi-year strategic collaboration to transform the plasmid sequencing market using nanopore technology. This partnership aims to deliver rapid, high-quality, and cost-effective whole-plasmid sequencing, with plans to co-develop new technologies and applications for microbial and gene therapy use cases.

Products Covered:

  • Instruments
  • Consumables
  • Services

Technologies Covered:

  • Single-Molecule Real-Time (SMRT) Sequencing
  • Nanopore Sequencing
  • Synthetic Long-Read Sequencing
  • Other Technologies

Applications Covered:

  • Genomics
  • Transcriptomics
  • Epigenetics
  • Metagenomics
  • Other Applications

End Users Covered:

  • Pharmaceutical & Biotechnology Companies
  • Clinical Laboratories
  • Hospitals & Healthcare Providers
  • Contract Research Organizations (CROs)
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Long Read Sequencing Market, By Product

  • 5.1 Introduction
  • 5.2 Instruments
    • 5.2.1 SMRT Sequencers
    • 5.2.2 Nanopore Sequencers
  • 5.3 Consumables
    • 5.3.1 Reagents
    • 5.3.2 Flow Cells
  • 5.4 Services
    • 5.4.1 Sequencing Services
    • 5.4.2 Data Analysis Services

6 Global Long Read Sequencing Market, By Technology

  • 6.1 Introduction
  • 6.2 Single-Molecule Real-Time (SMRT) Sequencing
  • 6.3 Nanopore Sequencing
  • 6.4 Synthetic Long-Read Sequencing
  • 6.5 Other Technologies

7 Global Long Read Sequencing Market, By Application

  • 7.1 Introduction
  • 7.2 Genomics
    • 7.2.1 Whole Genome Sequencing (WGS)
    • 7.2.2 De Novo Sequencing
    • 7.2.3 Structural Variant Detection
  • 7.3 Transcriptomics
    • 7.3.1 Full-Length mRNA Sequencing
    • 7.3.2 Isoform Identification
  • 7.4 Epigenetics
    • 7.4.1 DNA Methylation Analysis
    • 7.4.2 Histone Modification Detection
  • 7.5 Metagenomics
  • 7.6 Other Applications

8 Global Long Read Sequencing Market, By End User

  • 8.1 Introduction
  • 8.2 Pharmaceutical & Biotechnology Companies
  • 8.3 Clinical Laboratories
  • 8.4 Hospitals & Healthcare Providers
  • 8.5 Contract Research Organizations (CROs)
  • 8.6 Other End Users

9 Global Long Read Sequencing Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Pacific Biosciences
  • 11.2 Oxford Nanopore Technologies
  • 11.3 Illumina Inc.
  • 11.4 BGI Genomics
  • 11.5 MGI Tech
  • 11.6 10x Genomics
  • 11.7 Agilent Technologies
  • 11.8 Thermo Fisher Scientific
  • 11.9 Qiagen
  • 11.10 Bionano Genomics
  • 11.11 Element Biosciences
  • 11.12 Quantapore Inc.
  • 11.13 Universal Sequencing Technology
  • 11.14 BaseClear BV
  • 11.15 Cantata Bio, LLC
  • 11.16 Future Genomics Technologies B.V.
  • 11.17 MicrobesNG
  • 11.18 SeqLL, Inc.

List of Tables

  • Table 1 Global Long Read Sequencing Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Long Read Sequencing Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Long Read Sequencing Market Outlook, By Instruments (2024-2032) ($MN)
  • Table 4 Global Long Read Sequencing Market Outlook, By SMRT Sequencers (2024-2032) ($MN)
  • Table 5 Global Long Read Sequencing Market Outlook, By Nanopore Sequencers (2024-2032) ($MN)
  • Table 6 Global Long Read Sequencing Market Outlook, By Consumables (2024-2032) ($MN)
  • Table 7 Global Long Read Sequencing Market Outlook, By Reagents (2024-2032) ($MN)
  • Table 8 Global Long Read Sequencing Market Outlook, By Flow Cells (2024-2032) ($MN)
  • Table 9 Global Long Read Sequencing Market Outlook, By Services (2024-2032) ($MN)
  • Table 10 Global Long Read Sequencing Market Outlook, By Sequencing Services (2024-2032) ($MN)
  • Table 11 Global Long Read Sequencing Market Outlook, By Data Analysis Services (2024-2032) ($MN)
  • Table 12 Global Long Read Sequencing Market Outlook, By Technology (2024-2032) ($MN)
  • Table 13 Global Long Read Sequencing Market Outlook, By Single-Molecule Real-Time (SMRT) Sequencing (2024-2032) ($MN)
  • Table 14 Global Long Read Sequencing Market Outlook, By Nanopore Sequencing (2024-2032) ($MN)
  • Table 15 Global Long Read Sequencing Market Outlook, By Synthetic Long-Read Sequencing (2024-2032) ($MN)
  • Table 16 Global Long Read Sequencing Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 17 Global Long Read Sequencing Market Outlook, By Application (2024-2032) ($MN)
  • Table 18 Global Long Read Sequencing Market Outlook, By Genomics (2024-2032) ($MN)
  • Table 19 Global Long Read Sequencing Market Outlook, By Whole Genome Sequencing (WGS) (2024-2032) ($MN)
  • Table 20 Global Long Read Sequencing Market Outlook, By De Novo Sequencing (2024-2032) ($MN)
  • Table 21 Global Long Read Sequencing Market Outlook, By Structural Variant Detection (2024-2032) ($MN)
  • Table 22 Global Long Read Sequencing Market Outlook, By Transcriptomics (2024-2032) ($MN)
  • Table 23 Global Long Read Sequencing Market Outlook, By Full-Length mRNA Sequencing (2024-2032) ($MN)
  • Table 24 Global Long Read Sequencing Market Outlook, By Isoform Identification (2024-2032) ($MN)
  • Table 25 Global Long Read Sequencing Market Outlook, By Epigenetics (2024-2032) ($MN)
  • Table 26 Global Long Read Sequencing Market Outlook, By DNA Methylation Analysis (2024-2032) ($MN)
  • Table 27 Global Long Read Sequencing Market Outlook, By Histone Modification Detection (2024-2032) ($MN)
  • Table 28 Global Long Read Sequencing Market Outlook, By Metagenomics (2024-2032) ($MN)
  • Table 29 Global Long Read Sequencing Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 30 Global Long Read Sequencing Market Outlook, By End User (2024-2032) ($MN)
  • Table 31 Global Long Read Sequencing Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
  • Table 32 Global Long Read Sequencing Market Outlook, By Clinical Laboratories (2024-2032) ($MN)
  • Table 33 Global Long Read Sequencing Market Outlook, By Hospitals & Healthcare Providers (2024-2032) ($MN)
  • Table 34 Global Long Read Sequencing Market Outlook, By Contract Research Organizations (CROs) (2024-2032) ($MN)
  • Table 35 Global Long Read Sequencing Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.